Abstract

To what extent and how post-transcriptional dysregulation affects aging proteome remains unclear. Here, we provide proteomic data of whole-tissue lysates (WTL) and low-solubility protein-enriched fractions (LSF) of major tissues collected from mice of 6, 15, 24, and 30 months of age. Low-solubility proteins are preferentially affected by age and the analysis of LSF doubles the number of proteins identified to be differentially expressed with age. Simultaneous analysis of proteome and transcriptome using the same tissue homogenates reveals the features of age-related post-transcriptional dysregulation. Post-transcriptional dysregulation becomes evident especially after 24 months of age and age-related post-transcriptional dysregulation leads to accumulation of core matrisome proteins and reduction of mitochondrial membrane proteins in multiple tissues. Based on our in-depth proteomic data and sample-matched transcriptome data of adult, middle-aged, old, and geriatric mice, we construct the Mouse aging proteomic atlas (https://aging-proteomics.info/), which provides a thorough and integrative view of age-related gene expression changes.

Comprehensive investigation of proteome changes in old-age across mammalian tissues was missing. Here, the authors provide proteome and transcriptome data of major tissues of 6, 15, 24, and 30-month-old mice. Age-related post-transcriptional dysregulation most affects ECM and OXPHOS proteins.

Details

Title
An atlas of the aging mouse proteome reveals the features of age-related post-transcriptional dysregulation
Author
Takasugi, Masaki 1   VIAFID ORCID Logo  ; Nonaka, Yoshiki 1 ; Takemura, Kazuaki 1 ; Yoshida, Yuya 1 ; Stein, Frank 2   VIAFID ORCID Logo  ; Schwarz, Jennifer J. 2   VIAFID ORCID Logo  ; Adachi, Jun 3   VIAFID ORCID Logo  ; Satoh, Junko 4 ; Ito, Shinji 4 ; Tombline, Gregory 5 ; Biashad, Seyed Ali 5 ; Seluanov, Andrei 5   VIAFID ORCID Logo  ; Gorbunova, Vera 5 ; Ohtani, Naoko 6   VIAFID ORCID Logo 

 Graduate School of Medicine, Department of Pathophysiology, Osaka Metropolitan University, Osaka, Japan 
 EMBL Heidelberg, Proteomic Core Facility, Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X) 
 Health and Nutrition, Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Osaka, Japan (GRID:grid.482562.f) 
 Kyoto University, Medical Research Support Center, Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033) 
 University of Rochester, Department of Biology, Rochester, USA (GRID:grid.16416.34) (ISNI:0000 0004 1936 9174) 
 Graduate School of Medicine, Department of Pathophysiology, Osaka Metropolitan University, Osaka, Japan (GRID:grid.16416.34) 
Pages
8520
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3111718032
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.